Skip to main content
Premium Trial:

Request an Annual Quote

IsoPlexis IsoSpark, IsoSpark Duo Systems

IsoPlexis has launched its IsoSpark and IsoSpark Duo systems for functional proteomics. The IsoSpark has an 18-inch footprint and a 4-chip capacity, while the IsoSpark Duo has a 8-chip capacity to allow users to simultaneously run two chip families. The firm said that both systems are fully compatible with its suite of IsoPlexis applications. The systems are available for pre-order, with shipping planned for January 2021. 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.